Use of Subclavian Extracorporeal Carbon Dioxide Removal for COVID-19 Acute Respiratory Distress Syndrome as a Bridge to Lung Transplantation.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
aheadofprint
Résumé
Severe acute hypercapnia is independently associated with increased adverse effects and intensive care unit mortality in mechanically ventilated patients. During the severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic, some patients were placed on extracorporeal carbon dioxide removal support when extracorporeal membrane oxygenation (ECMO) support was at capacity or not offered. We present a patient with severe acute respiratory distress syndrome caused by COVID-19 pneumonia, who was supported with Hemolung Respiratory Assist System (ALung Technologies, Inc., LivaNova, Pittsburgh, PA) via the right subclavian vein as a bridge to lung transplantation after venovenous ECMO support. The patient survived and was discharged home.
Identifiants
pubmed: 37603812
doi: 10.1097/MAT.0000000000002018
pii: 00002480-990000000-00297
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © ASAIO 2023.
Déclaration de conflit d'intérêts
Disclosure: The authors have no conflicts of interest to report.
Références
Nin N, Muriel A, Penuelas O, et al.; VENTILA Group: Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome. Intensive Care Med 43: 200–208, 2017.
Kolobow T, Gattinoni L, Tomlinson T, White D, Pierce J, Iapichino G: The carbon dioxide membrane lung (CDML): A new concept. Trans Am Soc Artif Intern Organs 23: 17–21, 1977.
Bonin F, Sommerwerck U, Lund LW, Teschler H: Avoidance of intubation during acute exacerbation of chronic obstructive pulmonary disease for a lung transplant candidate using extracorporeal carbon dioxide removal with the Hemolung. J Thorac Cardiovasc Surg 145: e43–e44, 2013.
Saavedra-Romero R, Paz F, Litell JM, et al.: Treatment of severe hypercapnic respiratory failure caused by SARS-CoV-2 lung injury with ECCO2R using the Hemolung respiratory assist system. Case Rep Crit Care 2021: 9958343, 2021.
Ding X, Chen H, Zhao H, et al.: ECCO2R in 12 COVID-19 ARDS patients with extremely low compliance and refractory hypercapnia. Front Med (Lausanne) 8:654658, 2021.
Parienti JJ, Mongardon N, Megarbane B, et al.; 3SITES Study Group: Intravascular complications of central venous catheterization by insertion site. N Engl J Med 373: 1220–1229, 2015.
Richard JC, Marque S, Gros A, et al.; REVA research network: Feasibility and safety of ultra-low tidal volume ventilation without extracorporeal circulation in moderately severe and severe ARDS patients. Intensive Care Med 45: 1590–1598, 2019.
McNamee JJ, Gillies MA, Barrett NA, et al.; REST Investigators: Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: the rest randomized clinical trial. JAMA 326: 1013–1023, 2021.